OrbiMed Israel GP II, L.P.

10% owner at SteadyMed Ltd. · on record since Aug 12, 2016
Director at Upstream Bio, Inc. · on record since Oct 17, 2024
10% owner at Upstream Bio, Inc. · on record since Oct 17, 2024
Director at LogicBio Therapeutics, Inc. · on record since Oct 25, 2018
Director at 89bio, Inc. · on record since Nov 13, 2019
10% owner at 89bio, Inc. · on record since Nov 13, 2019
Director at Damora Therapeutics, Inc. · on record since Oct 28, 2020
10% owner at Damora Therapeutics, Inc. · on record since Oct 28, 2020
10% owner at Adicet Bio, Inc. · on record since Apr 9, 2026
Director at Adicet Bio, Inc. · on record since Sep 17, 2020
10% owner at LogicBio Therapeutics, Inc. · on record since Oct 25, 2018

Insider trading activity of OrbiMed Israel GP II, L.P.

Transactions on record: 33; since Sep 7, 2018

Open-market buys: 4; $22.9M

Open-market sells: 2; $18.9M

Companies traded: 4; last filing Dec 14, 2021

Figures computed from official regulatory filings — .

Companies where OrbiMed Israel GP II, L.P. has traded

Adicet Bio, Inc.1 tx · $3M · Dec 14, 2021
Damora Therapeutics, Inc.17 tx · $18.6M · Nov 4, 2020
LogicBio Therapeutics, Inc.7 tx · $11.9M · Oct 25, 2018
SteadyMed Ltd.8 tx · $19.4M · Sep 7, 2018

Track record of OrbiMed Israel GP II, L.P.

Statistical track record

Free

Open-market buys: 6

Last buy: Nov 2, 2020

Win rates and median returns are available with a free account (5 insiders/month).

Transaction history of OrbiMed Israel GP II, L.P.

Co-insiders of OrbiMed Israel GP II, L.P.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
Adicet Bio, Inc.	Dec 14, 2021	Award	214,285	14.00 USD	$3M	SEC
Damora Therapeutics, Inc.	Nov 4, 2020	AwardD (derivative)	-148,395	27.11 USD	$4M	SEC
Damora Therapeutics, Inc.	Nov 4, 2020	OtherD (derivative)	-73,773	—	—	SEC
Damora Therapeutics, Inc.	Nov 4, 2020	Buy	523,833	15.00 USD	$7.9M	SEC
Damora Therapeutics, Inc.	Nov 4, 2020	Other	191,787	—	—	SEC
Damora Therapeutics, Inc.	Nov 4, 2020	OtherD (derivative)	-272,533	—	—	SEC
Damora Therapeutics, Inc.	Nov 4, 2020	AwardD (derivative)	-73,773	27.11 USD	$2M	SEC
Damora Therapeutics, Inc.	Nov 4, 2020	OtherD (derivative)	-77,866	—	—	SEC
Damora Therapeutics, Inc.	Nov 4, 2020	Other	2,055,824	—	—	SEC
Damora Therapeutics, Inc.	Nov 4, 2020	Other	822,311	—	—	SEC
Damora Therapeutics, Inc.	Nov 4, 2020	OtherD (derivative)	-116,800	—	—	SEC
Damora Therapeutics, Inc.	Nov 4, 2020	OtherD (derivative)	-59,350	—	—	SEC
Damora Therapeutics, Inc.	Nov 4, 2020	OtherD (derivative)	-109,013	—	—	SEC
Damora Therapeutics, Inc.	Nov 4, 2020	OtherD (derivative)	-291,999	—	—	SEC
Damora Therapeutics, Inc.	Nov 4, 2020	Buy	209,500	15.00 USD	$3.1M	SEC
Damora Therapeutics, Inc.	Nov 4, 2020	AwardD (derivative)	-59,350	27.11 USD	$1.6M	SEC
Damora Therapeutics, Inc.	Nov 4, 2020	OtherD (derivative)	-31,147	—	—	SEC
Damora Therapeutics, Inc.	Nov 4, 2020	OtherD (derivative)	-148,395	—	—	SEC
LogicBio Therapeutics, Inc.	Oct 25, 2018	Other	2,279,023	—	—	SEC
LogicBio Therapeutics, Inc.	Oct 25, 2018	OtherD (derivative)	-4,352,775	0.00 USD	—	SEC
LogicBio Therapeutics, Inc.	Oct 25, 2018	Buy	490,000	10.00 USD	$4.9M	SEC
LogicBio Therapeutics, Inc.	Oct 25, 2018	Buy	700,000	10.00 USD	$7M	SEC
LogicBio Therapeutics, Inc.	Oct 25, 2018	Other	2,997,760	—	—	SEC
LogicBio Therapeutics, Inc.	Oct 25, 2018	OtherD (derivative)	-2,678,571	0.00 USD	—	SEC
LogicBio Therapeutics, Inc.	Oct 25, 2018	OtherD (derivative)	-3,046,943	0.00 USD	—	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Adicet Bio, Inc.	Dec 14, 2021	Award	214,285	14.00 USD	$3M	SEC
Damora Therapeutics, Inc.	Nov 4, 2020	AwardD (derivative)	-148,395	27.11 USD	$4M	SEC
Damora Therapeutics, Inc.	Nov 4, 2020	OtherD (derivative)	-73,773	—	—	SEC
Damora Therapeutics, Inc.	Nov 4, 2020	Buy	523,833	15.00 USD	$7.9M	SEC
Damora Therapeutics, Inc.	Nov 4, 2020	Other	191,787	—	—	SEC
Damora Therapeutics, Inc.	Nov 4, 2020	OtherD (derivative)	-272,533	—	—	SEC
Damora Therapeutics, Inc.	Nov 4, 2020	AwardD (derivative)	-73,773	27.11 USD	$2M	SEC
Damora Therapeutics, Inc.	Nov 4, 2020	OtherD (derivative)	-77,866	—	—	SEC
Damora Therapeutics, Inc.	Nov 4, 2020	Other	2,055,824	—	—	SEC
Damora Therapeutics, Inc.	Nov 4, 2020	Other	822,311	—	—	SEC
Damora Therapeutics, Inc.	Nov 4, 2020	OtherD (derivative)	-116,800	—	—	SEC
Damora Therapeutics, Inc.	Nov 4, 2020	OtherD (derivative)	-59,350	—	—	SEC
Damora Therapeutics, Inc.	Nov 4, 2020	OtherD (derivative)	-109,013	—	—	SEC
Damora Therapeutics, Inc.	Nov 4, 2020	OtherD (derivative)	-291,999	—	—	SEC
Damora Therapeutics, Inc.	Nov 4, 2020	Buy	209,500	15.00 USD	$3.1M	SEC
Damora Therapeutics, Inc.	Nov 4, 2020	AwardD (derivative)	-59,350	27.11 USD	$1.6M	SEC
Damora Therapeutics, Inc.	Nov 4, 2020	OtherD (derivative)	-31,147	—	—	SEC
Damora Therapeutics, Inc.	Nov 4, 2020	OtherD (derivative)	-148,395	—	—	SEC
LogicBio Therapeutics, Inc.	Oct 25, 2018	Other	2,279,023	—	—	SEC
LogicBio Therapeutics, Inc.	Oct 25, 2018	OtherD (derivative)	-4,352,775	0.00 USD	—	SEC
LogicBio Therapeutics, Inc.	Oct 25, 2018	Buy	490,000	10.00 USD	$4.9M	SEC
LogicBio Therapeutics, Inc.	Oct 25, 2018	Buy	700,000	10.00 USD	$7M	SEC
LogicBio Therapeutics, Inc.	Oct 25, 2018	Other	2,997,760	—	—	SEC
LogicBio Therapeutics, Inc.	Oct 25, 2018	OtherD (derivative)	-2,678,571	0.00 USD	—	SEC
LogicBio Therapeutics, Inc.	Oct 25, 2018	OtherD (derivative)	-3,046,943	0.00 USD	—	SEC